Literature DB >> 7213505

Pethidine clearance during continuous intravenous infusions in postoperative patients.

K L Austin, J V Stapleton, L E Mather.   

Abstract

1 Pethidine pharmacokinetics in ten female patients during continuous i.v. infusion for 32 h post-surgery have been determined. 2 The blood clearance of pethidine (mean +/- 2.d.) measured directly was 599 +/- 135 ml/min and is in marked contrast to some reported values. 3 Other model-dependent pharmacokinetic parameters were consistent with previously reported values. 4 Pethidine and indocyanine green clearance were correlated but the correlation was mediated through body weight. 5 Pethidine clearance and steady state concentration were predictable retrospectively from linear multivariable equations involving simple physical characteristics of the patient.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7213505      PMCID: PMC1401696          DOI: 10.1111/j.1365-2125.1981.tb01097.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  A pharmacokinetic approach to postoperative pain: continuous infusion of pethidine.

Authors:  J V Stapleton; K L Austin; L E Mather
Journal:  Anaesth Intensive Care       Date:  1979-02       Impact factor: 1.669

2.  Enhanced bioavailability and decreased clearance of analgesics in patients with cirrhosis.

Authors:  E A Neal; P J Meffin; P B Gregory; T F Blaschke
Journal:  Gastroenterology       Date:  1979-07       Impact factor: 22.682

3.  Meperidine and other basic drugs: general method for their determination in plasma.

Authors:  L E Mather; G T Tucker
Journal:  J Pharm Sci       Date:  1974-02       Impact factor: 3.534

4.  Effects of physical stress on the disposition of drugs eliminated by the liver in man.

Authors:  R D Swartz; F R Sidell; S A Cucinell
Journal:  J Pharmacol Exp Ther       Date:  1974-01       Impact factor: 4.030

5.  Disposition kinetics of lidocaine in normal subjects.

Authors:  M Rowland; P D Thomson; A Guichard; K L Melmon
Journal:  Ann N Y Acad Sci       Date:  1971-07-06       Impact factor: 5.691

6.  Meperidine kinetics in man. Intravenous injection in surgical patients and volunteers.

Authors:  L E Mather; G T Tucker; A E Pflug; M J Lindop; C Wilkerson
Journal:  Clin Pharmacol Ther       Date:  1975-01       Impact factor: 6.875

7.  A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol.

Authors:  R A Branch; J James; A E Read
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

8.  Lidocaine kinetics predicted by indocyanine green clearance.

Authors:  R A Zito; P R Reid
Journal:  N Engl J Med       Date:  1978-05-25       Impact factor: 91.245

9.  Plasma protein binding of valproic acid in healthy subjects and in patients with renal disease.

Authors:  R Gugler; G Mueller
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

Review 10.  Clinical pharmacokinetics of pethidine.

Authors:  L E Mather; P J Meffin
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

View more
  10 in total

1.  Continuous subcutaneous pethidine for routine postoperative analgesia.

Authors:  H T Davenport; D Al-Khudairi; P N Cox; B M Wright
Journal:  Ann R Coll Surg Engl       Date:  1985-11       Impact factor: 1.891

Review 2.  Clinical pharmacokinetics of pethidine: 1982.

Authors:  D J Edwards; C K Svensson; J P Visco; D Lalka
Journal:  Clin Pharmacokinet       Date:  1982 Sep-Oct       Impact factor: 6.447

3.  Pharmacokinetics of meperidine infusion.

Authors:  L E Mather; J B Bentley
Journal:  Can Anaesth Soc J       Date:  1982-11

4.  Determination of pharmacokinetic constants after multiple infusions of drugs.

Authors:  L E Mather; R L Ringrose; K L Austin
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

5.  Pulmonary disposition of pethidine in postoperative patients.

Authors:  M P Persson; P Hartvig; L Wiklund; L Paalzow
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

6.  Patient-controlled analgesic therapy. Part I: Pharmacokinetics of pethidine in the per- and postoperative periods.

Authors:  A Tamsen; P Hartvig; C Fagerlund; B Dahlström
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

7.  Pethidine binding in whole blood: methodology and clinical significance.

Authors:  C La Rosa; D J Morgan; L E Mather
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

Review 8.  Clinical pharmacokinetics of fentanyl and its newer derivatives.

Authors:  L E Mather
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

9.  The minimum effective analgetic blood concentration of pethidine in patients with intractable pain.

Authors:  L E Mather; C J Glynn
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

10.  Meperidine and skin surface warming additively reduce the shivering threshold: a volunteer study.

Authors:  Oliver Kimberger; Syed Z Ali; Monica Markstaller; Sandra Zmoos; Rolf Lauber; Corinne Hunkeler; Andrea Kurz
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.